Another group showed that metformin decreases EMT in breast cancer cells by diminishing key factors, such as zinc finger E-box binding homeobox 1, TWIST1, and snail family transcriptional repressor 2 [38]. This evidence concerns the gene ZEB1 and breast carcinoma.